Franklin J. Miller Sells 20,000 Shares of Merit Medical Systems, Inc. (MMSI) Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Franklin J. Miller sold 20,000 shares of the stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $60.44, for a total transaction of $1,208,800.00. Following the transaction, the director now owns 34,038 shares of the company’s stock, valued at $2,057,256.72. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Shares of MMSI stock opened at $60.89 on Friday. The company has a current ratio of 2.45, a quick ratio of 1.32 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $3.32 billion, a PE ratio of 36.03, a PEG ratio of 2.44 and a beta of 1.10. Merit Medical Systems, Inc. has a 52-week low of $43.05 and a 52-week high of $66.34.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Tuesday, February 26th. The medical instruments supplier reported $0.48 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.45 by $0.03. The firm had revenue of $232.25 million for the quarter, compared to analysts’ expectations of $231.03 million. Merit Medical Systems had a net margin of 4.76% and a return on equity of 11.26%. The business’s revenue was up 21.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.33 EPS. As a group, equities analysts forecast that Merit Medical Systems, Inc. will post 2.01 earnings per share for the current year.

MMSI has been the subject of a number of recent research reports. Needham & Company LLC restated a “buy” rating and set a $73.00 price objective on shares of Merit Medical Systems in a research note on Monday, December 17th. Zacks Investment Research downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Monday, December 31st. Finally, BidaskClub cut shares of Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 5th. One analyst has rated the stock with a sell rating, two have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $67.60.

Several large investors have recently made changes to their positions in the business. Neuburgh Advisers LLC grew its position in shares of Merit Medical Systems by 2.9% during the 4th quarter. Neuburgh Advisers LLC now owns 6,204 shares of the medical instruments supplier’s stock worth $346,000 after purchasing an additional 176 shares in the last quarter. Flinton Capital Management LLC grew its position in shares of Merit Medical Systems by 2.9% during the 4th quarter. Flinton Capital Management LLC now owns 9,588 shares of the medical instruments supplier’s stock worth $535,000 after purchasing an additional 272 shares in the last quarter. Comerica Bank grew its position in shares of Merit Medical Systems by 0.6% during the 4th quarter. Comerica Bank now owns 54,289 shares of the medical instruments supplier’s stock worth $2,897,000 after purchasing an additional 297 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Merit Medical Systems by 8.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,802 shares of the medical instruments supplier’s stock worth $212,000 after acquiring an additional 303 shares in the last quarter. Finally, First Mercantile Trust Co. boosted its position in shares of Merit Medical Systems by 7.5% during the 4th quarter. First Mercantile Trust Co. now owns 4,429 shares of the medical instruments supplier’s stock worth $247,000 after acquiring an additional 310 shares in the last quarter. Hedge funds and other institutional investors own 96.67% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another website, it was illegally stolen and reposted in violation of United States and international copyright and trademark law. The correct version of this article can be accessed at https://sportsperspectives.com/2019/03/17/franklin-j-miller-sells-20000-shares-of-merit-medical-systems-inc-mmsi-stock.html.

About Merit Medical Systems

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Further Reading: QQQ ETF

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.